Anti-CD38 targeted carfilzomib-loaded hybrid nanocomposites for multiple myeloma therapy: cytotoxicity and biodistribution.
Saved in:
| Title: | Anti-CD38 targeted carfilzomib-loaded hybrid nanocomposites for multiple myeloma therapy: cytotoxicity and biodistribution. |
|---|---|
| Authors: | Mishra D; Department of Pharmaceutics, Parul Institute of Pharmacy, Parul University, Vadodara, 391760, Gujarat, India., Patel A; Department of Pharmaceutics, Parul Institute of Pharmacy, Parul University, Vadodara, 391760, Gujarat, India. patelasha1405@outlook.com., Panjwani D; Department of Pharmaceutics, Institute of Pharmaceutical Sciences, Parul University, Vadodara, 391760, Gujarat, India., Patel S; Department of Pharmaceutics, Parul Institute of Pharmacy, Parul University, Vadodara, 391760, Gujarat, India., Kushwaha N; Department of Pharmaceutics, Parul Institute of Pharmacy, Parul University, Vadodara, 391760, Gujarat, India., Ahlawat P; Department of Pharmaceutics, Parul Institute of Pharmacy, Parul University, Vadodara, 391760, Gujarat, India., Patel V; Department of Civil and Petroleum Engineering, University of Alberta, Edmonton, Canada. |
| Source: | Discover oncology [Discov Oncol] 2026 Feb 27; Vol. 17 (1). Date of Electronic Publication: 2026 Feb 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2730-6011 |
|---|---|
| DOI: | 10.1007/s12672-026-04516-0 |
